HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Clinical trials for HIGH-GRADE B-CELL LYMPHOMA (HGBCL) explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE B-CELL LYMPHOMA (HGBCL) trials appear
Sign up with your email to follow new studies for HIGH-GRADE B-CELL LYMPHOMA (HGBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis study tests an experimental drug called epcoritamab (GEN3013) in people with several types of B-cell lymphoma that have relapsed (come back) or are refractory (did not respond to prior treatment). The main goals are to find the safest and most effective dose, monitor side ef…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can a simple vaccine boost CAR T-Cell success in lymphoma?
Disease control OngoingThis study looks at whether giving a pneumonia vaccine (PCV13) before and after CAR T-cell therapy can improve the immune system's ability to fight pneumococcus bacteria in people with certain types of lymphoma. About 26 participants with relapsed or hard-to-treat B-cell lymphoma…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 04, 2026 16:29 UTC